News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,090 Results
Type
Article (88682)
Company Profile (816)
Press Release (792563)
Multimedia
Podcasts (233)
Webinars (35)
Section
Business (233551)
Career Advice (4160)
Deals (39965)
Drug Delivery (175)
Drug Development (91657)
Employer Resources (207)
FDA (18540)
Job Trends (17477)
News (398631)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3048)
Academic (2)
Accelerated approval (53)
Adcomms (40)
Allergies (186)
Alliances (56987)
ALS (227)
Alzheimer's disease (1954)
Antibody-drug conjugate (ADC) (522)
Approvals (18855)
Artificial intelligence (840)
Autoimmune disease (335)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (209)
Brain cancer (83)
Breast cancer (815)
Cancer (6322)
Cardiovascular disease (541)
Career advice (3594)
Career pathing (51)
CAR-T (369)
CDC (76)
Celiac Disease (3)
Cell therapy (1037)
Cervical cancer (51)
Clinical research (78647)
Collaboration (2302)
Company closure (8)
Compensation (1461)
Complete response letters (103)
COVID-19 (3036)
CRISPR (120)
C-suite (1236)
Cystic fibrosis (164)
Data (8313)
Decentralized trials (3)
Denatured (88)
Depression (189)
Dermatology (93)
Diabetes (641)
Diagnostics (7541)
Digital health (62)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (412)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (310)
Earnings (102451)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (138013)
Executive appointments (1173)
FDA (22490)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1883)
Gene editing (266)
Generative AI (87)
Gene therapy (839)
GLP-1 (1257)
Government (5551)
Grass and pollen (8)
Guidances (413)
Healthcare (21144)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (350)
Immuno-oncology (106)
Indications (197)
Infectious disease (3422)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (306)
Interviews (820)
IPO (17995)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (115)
Layoffs (682)
Leadership (52)
Legal (10171)
Liver cancer (109)
Longevity (36)
Lung cancer (828)
Lymphoma (445)
Machine learning (65)
Management (66)
Manufacturing (1178)
MASH (213)
Medical device (15250)
Medtech (15387)
Mergers & acquisitions (23247)
Metabolic disorders (1721)
mRNA (258)
Multiple sclerosis (201)
NASH (24)
Neurodegenerative disease (485)
Neuropsychiatric disorders (125)
Neuroscience (3636)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5139)
Now hiring (79)
Obesity (831)
Opinion (370)
Ovarian cancer (235)
Pain (281)
Pancreatic cancer (326)
Parkinson's disease (400)
Partnered (39)
Patents (635)
Patient recruitment (716)
Peanut (67)
People (67848)
Pharmaceutical (136)
Pharmacy benefit managers (36)
Phase 1 (24300)
Phase 2 (34166)
Phase 3 (25685)
Pipeline (9245)
Policy (393)
Postmarket research (3559)
Preclinical (10945)
Press Release (72)
Prostate cancer (330)
Psychedelics (68)
Radiopharmaceuticals (359)
Rare diseases (1219)
Real estate (7461)
Recruiting (81)
Regulatory (30208)
Reports (78)
Research institute (2764)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (316)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4367)
State (2)
Stomach cancer (21)
Supply chain (142)
Tariffs (104)
The Weekly (142)
Vaccines (1286)
Venture capital (127)
Weight loss (573)
Women's health (136)
Worklife (24)
Date
Today (159)
Last 7 days (570)
Last 30 days (3678)
Last 365 days (33114)
2026 (14446)
2025 (33225)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (393)
Arkansas (16)
Asia (52162)
Australia (9175)
California (14034)
Canada (3940)
China (1489)
Colorado (599)
Connecticut (618)
Delaware (432)
Europe (120303)
Florida (2076)
Georgia (457)
Hawaii (4)
Idaho (69)
Illinois (1192)
India (100)
Indiana (649)
Iowa (25)
Japan (567)
Kansas (142)
Kentucky (56)
Louisiana (49)
Maine (89)
Maryland (1706)
Massachusetts (10238)
Michigan (420)
Minnesota (782)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (151)
New Hampshire (92)
New Jersey (3722)
New Mexico (34)
New York (3678)
North Carolina (1896)
North Dakota (11)
Northern California (6952)
Ohio (437)
Oklahoma (26)
Oregon (55)
Pennsylvania (2779)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5492)
Tennessee (222)
Texas (2276)
United States (50179)
Utah (420)
Vermont (1)
Virginia (356)
Washington D.C. (88)
Washington State (1150)
West Virginia (4)
Wisconsin (155)
Wyoming (2)
There are 882,090 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026
May 27, 2026
·
12 min read
Press Releases
Invivyd to Participate in Upcoming June 2026 Investor Events
May 27, 2026
·
1 min read
Press Releases
Maze Therapeutics to Participate in Two Upcoming June 2026 Investor Conferences
May 27, 2026
·
1 min read
IPO tracker
Kardigan cozies up to public markets to support heart disease drugs
Analysts are cautiously optimistic about an IPO rebound for biopharma.
BioSpace
is keeping track of companies that seek to trade on the public markets this year.
May 27, 2026
·
14 min read
·
Editorial Team
Press Releases
PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized Medicines
MEDBOTX™ represents the evolution into a broader point-of-care manufacturing platform designed for personalized medicines, peptides and advanced dose formats Potential U.S. peptide reclassification and possible inclusion of select peptides on the Section 503A Bulks List could create a timely opportunity for MEDBOTX™ in compounding pharmacies, hospitals and personalized medicine settings
May 27, 2026
·
12 min read
COVID-19
FDA assembles vaccine experts to update COVID-19 formulation
The FDA will convene its vaccines advisory panel to discuss seasonal COVID-19 vaccines—a surprise move after Health Secretary and vaccine skeptic Robert F. Kennedy, Jr. overhauled a separate vaccine committee.
May 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Kivo Expands Life Sciences Leadership Team with Appointment of Former Veeva Executive Chris Xistris
May 27, 2026
·
1 min read
Press Releases
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
May 27, 2026
·
1 min read
Breast cancer
AstraZeneca’s breast cancer pill hit with review delay after negative adcomm vote
An FDA advisory committee recently voted against approving AstraZeneca’s oral SERD drug camizestrant for certain patients with advanced breast cancer. It is unclear when the new target action date for the drug will be.
May 27, 2026
·
4 min read
·
Tristan Manalac
Cancer
Kura’s encouraging cancer drug data could unlock $2B market opportunity
Nearly 80% of patients saw tumor shrinkage after being treated with Kura Oncology’s darlifarnib plus Bristol Myers Squibb’s Krazati, findings Mizuho analysts say could open up a $2 billion opportunity for the biotech.
May 27, 2026
·
2 min read
·
Tristan Manalac
1 of 88,209
Next